Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rylo Health vs Semaglutide Online

Rylo Health
Graded #236

Lower grade

vs+9.599999999999994
Semaglutide Online
Graded #64

Higher grade

The verdict

Semaglutide Online takes it — 74.3/100 to 64.7/100.

Semaglutide Online grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Semaglutide Online is a LegitScript-certified telehealth platform prescribing compounded and brand-name GLP-1/GIP medications nationwide (excluding Alabama).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSemaglutide Online +2
64
66
Dose & formulationSemaglutide Online +32
64
96
Clinical oversightSemaglutide Online +6
75
81
Labs & monitoringRylo Health +1
53
52
FulfillmentSemaglutide Online +2
83
85
Contract termsSemaglutide Online +18
37
55
Rylo Health · left barSemaglutide Online · right bar

The numbers

MetricRylo HealthSemaglutide Online
WeighScore64.7/10074.3/100
GradeCC
Scorecard rank#236#64
Semaglutide$149/mo (promotional rate, compounded)$199/mo (all doses, compounded)
Tirzepatide$249/mo (compounded)$299/mo (all doses, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Rylo Health

Graded #236 · C

Strengths

  • Names its dispensing pharmacy in full, with address and phone: VialsRX in Houston, Texas
  • Names its medical group, Lone Star Virtual Health PLLC, and gives a provider contact
  • Standard prices published openly alongside the promotional rate, so the real ongoing cost is visible
  • Cancel in one click from the patient portal, with no contracts and no cancellation fees
  • Peptide line priced openly, including NAD+ and sermorelin

Where it loses points

  • Headline $100 and $160 rates are limited to the first 20 patients; standard rates are $149 and $249
  • No LegitScript certification is claimed or displayed
  • Several peptide products are advertised as coming soon rather than available
  • No published refund policy beyond the no-cancellation-fee statement
Semaglutide Online

Graded #64 · C

Strengths

  • LegitScript certified — passes accreditation standards recognized by Google and Visa for online telehealth
  • Compounded all-in pricing: semaglutide $199/mo and tirzepatide $299/mo includes medication, provider care, and shipping
  • Brand-name options (Wegovy pill, injectable sema, Zepbound) available for eligible patients, potentially $0-$25/mo with insurance
  • Nationwide (49 states + DC); no appointment required, licensed provider reviews intake within 12 hours
  • 0% financing through Credee from $79/month (12-24 months) plus Affirm and Klarna with ~97% approval rate

Where it loses points

  • No labs or clinical monitoring disclosed — blood work requirements not mentioned anywhere on site
  • Leadership team and medical director not identified on site — no named prescribers or company founders published
  • Brand-name prescriptions add a $44/month provider fee on top of medication cost, raising total price to $193-$343/mo
  • No coaching, dietitian, or behavioral support at any tier — medication and async provider access only
  • 30-day satisfaction guarantee covers evaluation fee only; medication costs explicitly non-refundable

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard